UNH
45
4
EIX
47
-11
CNP
47
6
UA
51
-5
ABT
57
3
THC
50
2
COST
54
4
SYK
50
8
GLW
50
-2
BIIB
39
-4
PHM
43
6
IBM
48
-2
MTCH
42
-4
PNR
53
3
VMC
33
3
SCHW
42
2
MMM
47
2
ZBH
65
-3
ADSK
61
4
ABBV
51
-4
UNH
45
4
EIX
47
-11
CNP
47
6
UA
51
-5
ABT
57
3
THC
50
2
COST
54
4
SYK
50
8
GLW
50
-2
BIIB
39
-4
PHM
43
6
IBM
48
-2
MTCH
42
-4
PNR
53
3
VMC
33
3
SCHW
42
2
MMM
47
2
ZBH
65
-3
ADSK
61
4
ABBV
51
-4
Financhill
Back

Singular Genomics Systems Vs. Nukkleus Industry Stock Comparison

Buy
53

OMIC
Singular Genomics Systems

Last Price:
$19.79
Seasonality Move:
-24.98%
Sell
23

NUKK
Nukkleus

Last Price:
$21.01
Seasonality Move:
48.46%
Buy
53
Singular Genomics Systems (OMIC) is a Buy

Is Singular Genomics Systems a Buy, Sell or Hold?

  • The current Singular Genomics Systems [OMIC] share price is $19.67. The Score for OMIC is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • OMIC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
23
Nukkleus (NUKK) is a Sell

Is Nukkleus a Buy, Sell or Hold?

  • The current Nukkleus [NUKK] share price is $21.00. The Score for NUKK is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • NUKK is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

OMIC Stock Price Chart

What is Singular Genomics Systems's stock price today?

  • The Singular Genomics Systems share price today is $19.67
    The current trend is relatively stagnant and OMIC is experiencing selling pressure, which indicates risk of future bearish movement.

NUKK Stock Price Chart

What is Nukkleus's stock price today?

  • The Nukkleus share price today is $21.00
    The current trend is moderately bearish and NUKK is experiencing slight selling pressure.

OMIC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.12 Sell
Relative Strength Index (14 RSI): 48.08 Sell
Chaikin Money Flow: -7514 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.34 - 20.42) Sell
Bollinger Bands (100): (10.44 - 21.44) Buy

NUKK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.09 Buy
Relative Strength Index (14 RSI): 48.74 Sell
Chaikin Money Flow: -90986 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.08 - 39.18) Sell
Bollinger Bands (100): (-5.25 - 19.13) Buy

OMIC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 19.63 Buy
20-day SMA: 19.7 Sell
50-day SMA: 20.15 Sell
200-day SMA: 13.26 Buy
8-day EMA: 19.66 Buy
20-day EMA: 19.8 Sell
50-day EMA: 19.11 Buy
200-day EMA: 16.27 Buy

NUKK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 30 Sell
20-day SMA: 26.02 Sell
50-day SMA: 11.64 Buy
200-day SMA: 6.16 Buy
8-day EMA: 27.7 Sell
20-day EMA: 25.09 Sell
50-day EMA: 16.11 Buy
200-day EMA: 13.92 Buy

Singular Genomics Systems Earnings Growth & OMIC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $7.61 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.17 per share, and an increase next year of $0.58 per share.

Nukkleus Earnings Growth & NUKK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Singular Genomics Systems Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nukkleus Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):